XML 42 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Common Stock Options and Warrants
9 Months Ended
Oct. 31, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

NOTE 9 - Common Stock Options and Warrants    


The Company's Stock Option Plan states that the exercise price of each option will be granted at an amount that equals the market value at the date of grant. All options vest at a time determined at the discretion of the Company's Board of Directors. All options expire if not exercised within 10 years from the date of grant, unless stated otherwise by the Board of Directors upon issuance.


The Company records compensation expense for the fair value of options granted under the Company's stock option plan. The Company estimates the fair value of each stock option at the grant date by using the Black-Scholes option-pricing model.


During the quarter ending April 30, 2012, the Company issued stock options of 2,500,000 to the officers and directors. The options were priced at $0.06 per share and expire five years from the date of issuance. The fair value of the option grant was estimated on the date of grant utilizing the Black-Scholes option pricing model. The fair value of these options was determined to be $99,924 based on the following assumptions: expected life of options of 5 years, expected volatility of 305.3%, risk-free interest rate of 1.01% and no dividend yield.


 

 

 

 

 

 

 

 

 

 




Options



Number of

Shares

Weighted

Average

Exercise

Price

Remaining

Contractual

Life

(in years)



Aggregate

Intrinsic Value

 

 

 

 

 

Outstanding at February 1, 2012

13,450,000

$0.25

2.02 yrs

$0.00

Issued

2,500,000

$0.06

4.38 yrs

$0.00

Exercised

-

-

-

 

Expired/Cancelled

(1,700,000)

$0.10

-

$0.00

Outstanding at October 31, 2012

14,250,000

$0.23

2.57 yrs

$0.00

Exercisable at October 31, 2012

14,250,000

$0.23

2.57 yrs

$0.00


The following table summarizes information about stock options at October 31, 2012:


 

 

 

 

 

 

 

 

 

 

 

 


Range

of

Prices

Weighted

Average

Number

Outstanding



Contractual

Life

Weighted Average

Exercise

Price

Weighted

Average

Number

Exercisable

Weighted

Average

Exercise

Price

 

 

 

 

 

 

$0.05

2,000,000

3.55 yrs

$0.05

2,000,000

$0.05

$0.06

3,150,000

2.22 yrs

$0.06

3,150,000

$0.06

$0.08

500,000

2.22 yrs

$0.08

500,000

$0.08

$0.30

100,000

2.22 yrs

$0.30

100,000

$0.30

$0.40

4,000,000

.10 yrs

$0.40

4,000,000

$0.40

$0.60

2,000,000

3.10 yrs

$0.60

2,000,000

$0.60

$0.06

2,500,000

4.38 yrs

$0.06

2,500,000

$0.06


During the year ended January 31, 2011, the Company issued 6,626,486 warrants in connection with a private placement. The warrants are exercisable for a period of two years for $0.12 per share. However, if the common shares trade at over $0.18 per share in any 20-day period during the life of the warrants, the Company has the right to accelerate the expiration date of the warrants. Warrants in the amount of 2,859,820 were exercised by two shareholders in settlement of debt. During the nine months ended October 31, 2012, 3,766,666 warrants expired.


On June 19, 2012 the Company issued 2,000,000 shares of common stock and a warrant to purchase 1,000,000 shares of common stock at $0.05 per share within a three year period.


On August 31, 2012, in connection with a note payable, the Company entered into a Warrant Purchase Agreement with an unaffiliated accredited investor. As part of the terms of the note, the Company issued a five year warrant to the lender to purchase 6,814,000 shares of Company common stock, exercisable at $0.02 per share. The fair value of these warrants at the date of grant was $132,332 using a Black Scholes option pricing model and the following assumptions: expected life of warrants is five years, expected volatility rate of 194.81%, risk free rate of 0.59%, and an exercise price of $0.02.  The $132,332 was amortized to interest expense over the term of the bridge loan.    


On October 31, 2012, the Company had the following outstanding warrants:


 

 

 

 

 

 



Exercise

Price



Number

of Shares


Remaining

Contractual

Life

Exercise Price

Times Number

of Shares

Weighted

Average

Exercise Price


Aggregate Intrinsic Value

 

 

 

 

 

 

$0.05

1,000,000

2.63 yrs

$50,000

$0.05

$0.00

$0.02

6,814,000

4.84 yrs

$136,280

$0.02

$0.00